<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00489398</url>
  </required_header>
  <id_info>
    <org_study_id>5316</org_study_id>
    <nct_id>NCT00489398</nct_id>
  </id_info>
  <brief_title>Comparison of CL Wear Between Two Allergy Drops</brief_title>
  <official_title>Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hom, Milton M., OD, FAAO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hom, Milton M., OD, FAAO</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contact lens patients will instill allergy drops and subjective and objective tests will be
      performed
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Protocol changes
  </why_stopped>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contact lens objective and subjective clinical performance testing</measure>
    <time_frame>up to 3 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Allergic Conjunctivitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epinastine HCL and olopatadine HCL</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females &gt; 18 years old

          -  Mild to moderate dry eye symptoms

          -  Likely to complete all study visits and able to provide informed consent

        Exclusion Criteria:

          -  Current use of topical cyclosporine

          -  Known contraindications to any study medication or ingredients

          -  Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are
             actively being treated or disease that is uncontrollable)

          -  Ocular surgery within the past 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milton M Hom, OD FAAO</last_name>
    <role>Study Director</role>
    <affiliation>Private Practice</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2007</study_first_submitted>
  <study_first_submitted_qc>June 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2007</study_first_posted>
  <last_update_submitted>October 5, 2010</last_update_submitted>
  <last_update_submitted_qc>October 5, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Milton M. Hom, OD, FAAO.</name_title>
    <organization>Milton M. Hom, OD, FAAO.</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olopatadine Hydrochloride</mesh_term>
    <mesh_term>Epinastine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

